DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings C

Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Third Quarter 2023 Conference Call.

Related Keywords

Australia , Canada , China , Netherlands , Australian , Dutch , Canadian , Alexander Nowak , Scott Kellen , Rick Pauls , Alex Nowak , Qambar Shah , Dave Wambeke , Thomas Flaten , Human Genome Sciences , Glaxosmithkline , National Institute Of Health Stroke Scale , Head Of Global Vaccines Development , Astrazeneca , Nasdaq , Diamedica Therapeutics Inc , Most Valuable It Companies , Technology Officer , Pfizer , Diamedica Therapeutics , Call Transcript November , Diamedica Therapeutics Third Quarter , Investor Relations , Cautionary Statement Note , Risk Factors , Chief Executive , Chief Financial , Chief Technology , Vice President , Global Vaccines Development , Executive Director , Drug Product Development , Bristol Myers Squib , Scientific Advisory Board , Interim Chief Medical Officer , Jordan Dubow , National Institute , Health Stroke Scale , Rankin Scale , Chief Business Officer , Lake Street ,